Atlas Trials

Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis

Clinical trial NCT03209219 · COMPLETED

Trial details

NCT number
NCT03209219
Sponsor
Peking Union Medical College Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Behçet DiseaseUveitis
Start date
2017-06-30
Primary completion
2020-08-31
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.